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Abstract
Background: Huntington's disease, spinal and bulbar muscular atrophy, and spinocerebellar ataxia
17 (SCA17) are caused by expansions in the polyglutamine (polyQ) repeats in Huntingtin protein
(Htt), androgen receptor protein (AR), and TATA-binding protein (TBP), respectively. Htt-
associated protein 1 (HAP1), a component of neuronal cytoplasmic stigmoid bodies (STBs), can
sequester polyQ-expanded Htt and AR in STBs, thereby antagonizing formation of the nuclear
aggregates associated with apoptotic neuron loss and disease progression.
Results: Clones of HAP1 were isolated from unbiased two-hybrid screens for proteins that
interact with TBP. Domain mapping showed that regions between amino acids 157 and 261 and
between amino acids 473 and 582 of mouse HAP1 both bind specifically to the conserved C-
terminal TBPCORE domain, away from the TBP N-terminal polyQ region. When fluorescently tagged
versions of HAP1 or TBP were expressed independently in COS-7, 293, or Neuro-2a cells, all TBP
localized to the nucleus and all HAP1 assembled into cytoplasmic stigmoid-like bodies (STLBs).
When co-expressed, a portion of the TBP was assembled into the HAP1 STLBs while the
remainder was localized to the nucleus. Although the TBP N terminus, including the polyQ region,
was unnecessary for TBP-HAP1 interaction, in mammalian cells, removal of the TBP Qrepeat
reduced the proportion of TBP that assembled into STLBs, whereas expansion of the Qrepeat had
no significant affect on TBP subcellular localization.
Conclusion: HAP1 can sequester a subset of TBP protein away from the nucleus; extranuclear
TBP sequestration is quantitatively influenced by the TBP polyQ repeat. These results suggest
HAP1 could provide protection from SCA17 neuropathology.
Background
The Huntingtin-associated protein, HAP1, was first iden-
tified as a protein that interacts with Huntingtin protein
(Htt), the causative agent of Huntington's disease (HD)
[1-5]. HD is a member of a family of diseases in which
expanded polyglutamine (polyQ) repeat regions in an
otherwise functionally diverse group of proteins results in
neurodegenerative disorders [1,3,6]. This family includes
dentatorubral-palidoluysian atrophy (DRPLA), caused by
polyQ expansion in atrophin 1; [7,8], spinal and bulbar
muscular atrophy (SBMA or Kennedy's disease), caused by
polyQ expansion in the androgen receptor, AR; [9-11],
and spinocerebellar ataxias 1–3, 6, 7, and 17 (SCAs),
caused by polyQ expansions in various proteins [1,3].
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In all of these diseases, expansion of gene sequences
encoding the polyQ region of the individual protein
results in the disease in later life [1,3]. All are associated
with neuronal accumulation of nuclear aggregates con-
taining the affected protein as well as other proteins [1,3].
Although some extranuclear protein aggregates can often
also be found, the nuclear accumulations are implicated
in inducing the cytopathic state that leads to apoptotic
loss of neurons [1]. In the case of HD, expansion of the
polyQ repeat beyond ~36 residues causes an amino- (N-)
terminal fragment (encoded by exon 1 of the htt gene) to
be cleaved and to translocate to the nucleus, where it
becomes incorporated into neuronal nuclear aggregates
[12-14]. Nuclear HD aggregates typically contain proteas-
ome subunits, chaperones, and ubiquitin [1,3,15,16].
Aggregates also contain transcription factors, including
the TATA-binding protein (TBP), cyclic AMP response ele-
ment-binding protein (CBP), specificity factor 1 (SP1),
p53, and others [17,18]. One of these, TBP, is a general
transcription factor that functions in initiation by all three
nuclear RNA polymerases [19]. In addition, TBP is, itself,
a polyQ protein that, upon expansion of its polyQ repeat,
forms intranuclear aggregates leading to the SCA17 neu-
ropathology [20]. Although TBP is generally a low abun-
dance protein in normal somatic cells [21,22], the nuclear
aggregates in SCA17 accumulate to high levels [23], sug-
gesting that the pathological state is associated with
increased accumulation of nuclear TBP.
Although HAP1 interacts with Htt, it is unclear what role
this might play in HD. Recent evidence suggests that
HAP1 may protect against polyQ-expansion neuropathol-
ogies [24-27], a proposal known as the 'HAP1 protection
hypothesis' [25]. Thus, although expanded polyQ Htt is
abundant throughout the brain, including in the HAP1-
expressing hypothalamic and limbic regions in HD
patients [25,28,29], these areas do not accumulate Htt
aggregates and do not exhibit HD pathology [30]. Moreo-
ver, evidence for a neuroprotective role of HAP1 in SBMA
has been reported. Thus, HAP1 binds to AR and SBMA
pathology is generally not seen in neurons expressing
HAP1 [27]. Importantly, whereas transfection of HEp-2
cells with polyQ-expanded AR results in apoptosis, co-
transfection of HAP1 abrogates this effect [27].
Two HAP1 isoforms have been characterized in mice,
HAP1-A, a 598 amino acid protein, and HAP1-B, a 628
amino acid protein, which both arise from the same gene
[31]. The difference between HAP1-A and HAP1-B stems
from alternative splicing in the 3' region of the pre-mRNA
and results in both proteins containing different C-termi-
nal sequences beyond the 577 amino acid HAP1 common
region [31-33]. It is not yet clear how HAP1-A and HAP1-
B might differ functionally, although the predominant
vesicle-associated subtype is HAP1-B [32].
Subcellular localization studies show that HAP1 is pre-
dominantly cytoplasmic [34]. HAP1 is a component of
stigmoid bodies (STBs) [34], which are non-membrane-
bound cytoplasmic inclusions found in the hypothala-
mus and limbic regions of the brain [35]. HAP1 expres-
sion induces formation of cytoplasmic inclusions
resembling STBs, here termed stigmoid-like bodies
(STLBs), in 293 human embryonic kidney carcinoma
cells, HEp-2 human larynx carcinoma cells, and mouse
neuronal NIE 115 cells [27,36], suggesting that HAP1-A
directs assembly of similar cytoplasmic inclusions in neu-
ronal and non-neuronal cell types.
In the study presented here, unbiased yeast two-hybrid
screens identified HAP1 as a protein that binds to TBP.
Like the HAP1-interacting Htt and AR proteins, TBP is the
causative agent of a polyQ-expansion-dependent neu-
ropathology (see above). Moreover, like for Htt and AR
proteins, we found that binding of HAP1 to TBP occurred
away from the TBP polyQ region. Instead, interaction
domain mapping studies showed that HAP1 binds specif-
ically to the conserved C-terminal domain of TBP (TBP-
CORE). By inducing formation of green fluorescent protein-
tagged HAP1 STLBs in 293, COS-7, or Neuro-2A cells, we
show that cytoplasmic STLBs sequester some TBP while
still allowing accumulation of substantial levels of TBP in
the nucleus. These data suggest HAP1 can specifically
associate with TBP to prevent nuclear localization of
excess TBP while not impeding normal nuclear TBP accu-
mulation and function.
Results
Identification of HAP1 as a TBP interacting protein
To identify proteins that interacted with TBP, we screened
a mixture of oligo(dT)-primed placental and whole preg-
nant uteri cDNA libraries (50% of each library was used)
(screen #1) or a random-primed library which also con-
sisted of 50% placental and 50% whole pregnant mouse
uteri cDNAs (screen #2). Both screens were performed
using TBP-FL as the bait protein, which was expressed
from the pDBLeu plasmid (Fig. 1). In screen #1, ~6 × 106
primary transformants (yeast containing both a bait and
prey plasmid) were plated onto SC-L-W-H-U. From these
plates, 82 colonies grew and were transferred to fresh SC-
L-W-H-U plates and those clones that re-grew were further
tested for activation of the LacZ reporter gene. Seven of the
clones grew on SC-L-W-H + 50 mM 3-AT, SC-L-W-H + 75
mM 3-AT, SC-L-W-H-U, and also activated the LacZ
reporter gene (data not shown). Inserts were sequenced to
identify the interacting protein. Three clones encoded par-
tial cDNAs of B'-related factor 1 (BRF1), a known TBP
interacting protein [37]. A fourth clone encoded a nearly
full-length HAP1-A protein, beginning at amino acid 7
(HAP17–598). The remaining three clones encoded the fol-
lowing proteins: an unknown protein with similarity toBMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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Yeast two-hybrid bait constructs, prey libraries, and screens Figure 1
Yeast two-hybrid bait constructs, prey libraries, and screens. (A) Bait constructs. TBP-FL, TBP-C, and TBP-N were expressed 
from the pDBLeu plasmid, which fused the Gal4 DNA-binding domain (DBD) upstream of TBP. N and C designate the verte-
brate-specific N terminus and the pan-eukaryotic TBPCORE, respectively. (B) Three prey libraries were constructed and 
inserted into pPC86, which fused prey cDNAs downstream of the Gal4 activation domain (AD). Characteristics of each library 
are indicated. Libraries were constructed from oligo(dt)-primed placental and pregnant uteri RNA or from random-primed pla-
centa + pregnant uteri RNA (p+u). Below is shown PCR analysis of arbitrary clones from both of the oligo(dT)-primed libraries 
using a primer pair that spans the multiple cloning site of the vector. Lane "λ" contained Hind III/Eco RI-cut λ-phage DNA mark-
ers. Landmark band sizes are indicated at the left of each gel; the asterisk denotes the size of the PCR product arising from 
empty prey vector. (C) The results of the two yeast two-hybrid screens performed are shown. In both screens, TBP-FL was 
used as bait to screen either the oligo(dT)- or random-primed placenta + uteri prey libraries for interacting proteins. TBP-
interacting prey library clones were subsequently identified by sequencing.BMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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human SR-rich proteins (accession number BAB30779)
[38]; an unknown protein product containing similarity
to chromosome segregation ATPases (accession number
BAE22251); and Rho-associated coiled-coil forming
kinase 1 (accession number NM_009071), a serine-threo-
nine protein kinase.
In screen #2, using the random-primed prey library, ~1.7
× 107 primary transformants were plated and tested as in
screen #1. Out of 183 colonies that grew on SC-L-W-H-U,
five yeast clones activated all three reporter genes (HIS3,
ADE2, and LacZ), did not grow in the presence of an
empty bait plasmid (no TBP insert; data not shown), and
thus appeared to express a TBP-interacting prey protein.
One of these clones encoded amino acids 155–582 of the
HAP1-B (HAP1155–582) protein, with only the last five
amino acids extending beyond the HAP1-common
domain and into the HAP1-B-specific region. The other
four clones were identical clones of cyclic AMP-dependent
protein kinase regulatory protein α (accession number
AAH03461) [39]. The interaction of the random-primed
HAP1 clone with TBP-FL is shown in Figure 2A, sector 1.
The HAP1-TBP-FL interaction and control protein interac-
tion pairs are shown in Figure 2A, sectors 1 and 7–8,
respectively.
Interaction of HAP1 with TBP domains
To determine whether HAP1 interacted with the con-
served TBPCORE or the vertebrate-specific TBP N terminus,
yeast were co-transformed with either TBP-N or TBP-C
bait plasmids and the HAP1155–582 prey plasmid. Growth
of all clones on SC-L-W verified the presence of both the
bait and prey plasmids (Fig. 2A, left panel). In the pres-
ence an empty prey plasmid, TBP-FL, TBP-C, and TBP-N
did not grow under the protein interaction selection con-
ditions (Fig. 2A, sectors 4–6). Similarly, yeast that con-
tained either the empty bait or empty prey plasmids
(negative controls) did not grow on plates that selected for
interaction of bait and prey proteins (Fig. 2A, sector 9,
panels 2, 3). The HAP1155–582 clone interacted with the
TBPCORE (Fig. 2A, sector 2, panels 2, 3), but not with TBP
N (Fig. 2A, sector 3, panels 2, 3).
The interaction of HAP1 with Htt or AR has been shown
to occur away from the polyQ repeat region in each pro-
tein, but to be influenced by expansion of the polyQ
repeat [12,27]. In two-component two hybrid screens, we
found a strong interaction of HAP1 with either the TBP-
CORE alone (lacking the N-terminal polyQ region; Fig. 2A,
sector 2, panels 2, 3) or with full length TBP protein in
which the polyQ region had been replaced by two glycine
residues (TBP-∆Q; Fig. 2B). Thus, the TBP polyQ region
showed no measurable contribution to the interaction of
HAP1 with TBP in the yeast two-hybrid system.
All attempts at further truncating the TBPCORE region to
define the interaction domain on TBP disrupted the TBP-
HAP1 interaction (Fig. 2B, sectors 2–6), suggesting that
the interaction might be dependent on the structural
integrity of the entire TBPCORE region.
Interaction of TBP with HAP1 in co-transfected cells
In mammals, protein domains resembling the TBPCORE
region are found only in TBP and its two homologues
[40,41]. Similarly, the TBP-interacting domains in HAP1
are not found in other proteins [33]. Thus, the TBP-HAP1
interaction appeared to be a specific interaction between
unique polypeptide domains. For verification, the interac-
tions between TBP and HAP1 identified by two-hybrid
screens were tested by co-immunoprecipitation in mam-
malian cell culture. Differently epitope-tagged versions of
full-length TBP and HAP1155–582  were co-expressed in
transiently transfected 293 cells. Results indicated that
HAP1 co-precipitated with TBP when both proteins were
co-expressed, but was not detected using a species-
matched, nonspecific antibody (Fig. 3A). In a similar
experiment, epitope-tagged HAP1155–582  co-precipitated
with a GFP-TBP fusion protein (Fig. 3B), again verifying
the interaction between HAP1 and TBP in mammalian
cells.
Mapping the TBP-interaction domain on HAP1
To identify the domain of HAP1 that interacted with TBP,
we constructed truncated versions of HAP1 in the pDBLeu
bait vector (Figs 4, 5). Each of the HAP1 truncated clones
was tested for interaction with TBP-C and TBP-N in the
two-hybrid system (Fig. 4, bottom panel). We found that
all clones that began at amino acid 157 interacted with
TBP-C (Fig. 4, sectors 1, 4, 7, 28, and 31; Fig 5), but not
with TBP-N (Fig. 4, sectors 2, 5, 8, 29, and 32). The short-
est N-terminal fragment of HAP1 that interacted with TBP
encoded amino acids 157–261, which suggested that a
TBP interacting region was between amino acids 157–261
of the HAP1 protein. The linear sequence of amino acids
within TBP interacting region 1 is shown in Fig. 5. In addi-
tion, the lack of interaction between TBP-C and HAP1238–
479 (Fig. 4, sector 13) suggested that this TBP interacting
region on HAP1 required amino acids 157–237.
Some HAP1 clones that encoded amino acids outside TBP
interacting region 1 also interacted with TBP-C (Fig. 4, sec-
tors 16, 25, 34, and 37) but not with TBP-N (Fig. 4, sectors
17, 26, 35, and 38). The shortest C-terminal HAP1 clone
that interacted with TBP-C encoded amino acids 473–
582, which suggested that a second TBP interaction
domain resided between amino acids 473–582 of HAP1.
This region is represented as the TBP interacting region 2
in Fig. 5. The amino acid sequences of TBP interacting
domains 1 and 2 show no obvious similarity (Fig. 5, bot-
tom), suggesting that these are each unique interactingBMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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Protein interactions in the yeast two-hybrid system Figure 2
Protein interactions in the yeast two-hybrid system. Bait and prey plasmid combinations within individual yeast clones are indi-
cated below. Sector designations correspond to those on plates. Growth of yeast on SC-L-W indicated that clones contained 
both the bait and prey plasmid. (A) Interaction with TBP-FL, TBP-N, and TBP-C. Sectors 1–3 show the interaction of HAP1-
B155–582 with TBP-FL, TBP-C, or TBP-N, respectively. The interaction of HAP1 with TBP-FL and TBP-C, but not TBP-N 
resulted in growth under all conditions tested. Sectors 4–6 were auto-activation controls for TBP baits. Sectors 7–8 contained 
strong and weak positive interaction controls, respectively, that were supplied with the ProQuest system. The strong interac-
tion control grew well under all conditions tested. The weak interaction control did not grow on SC-L-W-H-U, suggesting that 
this condition allowed growth of yeast containing only strong bait-prey interactions. Sector 9 was a negative auto-activation 
control showing that yeast bearing only the empty bait vector and an empty prey plasmid (no inserts) did not grow under con-
ditions that selected for interacting bait-prey protein pairs. (B) Finer TBP deletions. Sectors 1–6 show the interaction of HAP1-
A7–598 with TBP-∆Q (sector 1) and truncated TBP-C clones (as indicated in table below; sectors 2–6). HAP1 interacted with 
TBP-∆Q under all conditions tested (sector 1), but did not interact with any of the truncated TBP-C clones (sectors 2–6), sug-
gesting that an intact TBPCORE is required for the HAP1-TBP interaction to occur. Sectors 7–12 were auto-activation controls 
for TBP baits, of which none were auto-active.BMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
Page 6 of 18
(page number not for citation purposes)
Co-immunoprecipitation assay Figure 3
Co-immunoprecipitation assay. TBP/HAP1-B155–582 interactions in co-transfected cells. (A) 293 cells were co-transfected with 
pCMV-HA-TBP-FL and pCMV-MYC-HAP1. Whole cell lysates (WCL) (lanes 1–2, where lane 1 and lane 2 represent 4% of 
each WCL used for immunoprecipitation in lanes 3 and 4, respectively) or immunoprecipitated samples (lanes 3–4) were 
assayed using western blots with anti-MYC antibody. MYC-tagged HAP1 co-precipitated with TBP in the presence of the anti-
TBP antibody (lane 3), but not with the non-specific antibody (lane 4). (B) COS-7 cells were co-transfected with pFLAG-CMV-
GFP-TBP-FL (lanes 1–4, 7–8) or pFLAG-CMV-GFP (lanes 5–6, 9) and pCMV-MYC-HAP1-B155–582 (lanes 1–9). Whole cell 
lysates (lanes 1, 3, and 5, HAP1) or immunoprecipitated samples (lanes 2, 4, and 6, HAP1) were assayed using western blots 
and anti-MYC antibody. MYC-tagged HAP1 co-precipitated with FLAG-tagged-GFP-TBP in the presence of the anti-FLAG anti-
body (lane 2), but not with the non-specific antibody (lane 4). Myc-tagged HAP1 did not co-precipitate with FLAG-tagged-GFP 
in the presence of anti-FLAG antibody (lane 6). 30% of each immunoprecipitated sample was also blotted with anti-FLAG anti-
body (lanes 7–9) to verify the amount of FLAG-tagged protein that was captured in each co-precipitation assay (lanes 7–9 rep-
resent co-precipitated samples in lanes 2, 4, and 6, respectively).BMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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domains rather than redundant versions of the same
domain.
Intracellular co-localization of TBP and HAP1
The TBP-HAP1 interaction was unexpected because, to
our knowledge, following its synthesis in the cytoplasm,
all TBP localizes to the nucleus [19]. Conversely, HAP1 is
predominantly a cytoplasmic protein [34,42]. Neverthe-
less, the appearance of HAP1 in TBP-interaction screens
using different libraries as well as the apparent specificity
of interaction with the highly conserved TBPCORE region
(Figs 2, 4) encouraged us to test whether we could detect
colocalization of these two proteins in living cells. Expres-
sion vectors encoding TBP or HAP1-A fused to red or
Identification of TBP/HAP1 interaction domains Figure 4
Identification of TBP/HAP1 interaction domains. The interaction of truncated HAP1 clones with TBP-C, TBP-N, and auto-acti-
vation controls are shown. Yeast containing the indicated bait and prey plasmids (listed below) were grown on SC-L-W (top 
panel), which selects for the presence of the bait and prey plasmids, and SC-L-W-H + 50 mM 3-AT (bottom panel), which 
selects for the interaction between bait and prey. All baits were expressed from the pDBLeu plasmid and all truncated HAP1 
preys were expressed from the pPC86 plasmid. Sectors 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, and 39 were controls confirm-
ing that truncated HAP1 clones were not auto-active. Sectors 2, 5, 8, 11, 14, 17, 20, 23, 26, 29, 32, 35, and 38 confirmed that 
none of the HAP1 clones interacted with TBP-N. Clones 10, 13, 19, and 22 did not grow on SC-L-W-H + 50 mM 3-AT, which 
suggested that these clones lacked the TBP interaction domain, whereas growth of clones 1, 4, 7, 16, 25, 28, 31, 34, and 37 on 
SC-L-W-H + 50 mM 3-AT suggested that these clones contained a TBP interaction domain. Three independent clones of all 
HAP1 truncations were tested and each gave the same result; one representative set is shown.BMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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green fluorescent proteins, respectively, were constructed
and transfected either individually (Fig. 6A) or in combi-
nation into COS-7, 293, or Neuro-2a cells (Fig. 6B). As
negative controls, other nuclear proteins were fused to the
red fluorescent protein and transfected either alone or in
combination with GFP-HAP1. Specifically, we chose three
representative proteins: MED15 (PCQAP), a component
of the mediator [43,44], which is closely associated with
TBP and the basal transcription machinery; PTIP [45], a
DNA-binding transcription factor that associates with
active chromatin; and U2AF65 (U2AF2), a component of
the splicing machinery [46,47].
When either red fluorescently labeled TBP, MED15, PTIP,
or U2AF65 were transfected alone, each of these proteins
localized exclusively to the nucleus where each exhibited
distinct heterogenous distributions (Fig. 6A). Conversely,
fluorescently labeled HAP1 was exclusively cytoplasmic,
where it assembled into STLBs [42] (Fig. 6A). In cells
expressing both TBP and HAP1, however, a portion of the
TBP co-localized with HAP1 in cytoplasmic STLBs (Fig.
6B). We did not detect any HAP1 redistributing to the
nucleus with TBP. Co-expression of HAP1 with either
MED15, PTIP, or U2AF65 did not result in any redistribu-
tion of these non-TBP nuclear proteins into STLBs (Fig.
6B). These results suggest that TBP can be sequestered in
cytoplasmic STLBs in vivo via specific interactions with
HAP1. Importantly, not all TBP was sequestered in STLBs
(Fig. 6B). This suggests the association did not disrupt
normal nuclear localization and function of TBP, but
rather, was selective for only a subset of TBP in the cells.
HAP1-A has been shown to have a strong propensity
toward forming STLBs in mammalian cells, whereas
HAP1-B has been reported to have a more diffuse cyto-
plasmic expression pattern [36,48]. Our interaction data
showed that TBP interacts with HAP1 in the region that is
common to both HAP1 isoforms (Figs 4, 5). Moreover,
Deletion analysis of the TBP interacting regions on HAP1 Figure 5
Deletion analysis of the TBP interacting regions on HAP1. (A) The full-length HAP1-B protein is represented at top, including 
the location of the known acidic domain (AcD) and the two coiled coil domains. HAP1 amino acids encoded by each cDNA 
clone in pPC86 are shown at left. The presence (+) or absence (-) of interaction with TBP-C is shown at right. Results sug-
gested that the TBP interacting regions on HAP1 were between amino acids 157 and 261, and between amino acids 473 and 
582. (B) Amino acid sequences of HAP1 TBP-interacting regions.BMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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TBP and HAP1 co-localization assay in COS-7, 293, and Neuro-2a cells Figure 6
TBP and HAP1 co-localization assay in COS-7, 293, and Neuro-2a cells. (A) cells transfected with a single expression plasmid, 
as indicated at top. Forty-eight hours after transfection, cells were stained with Hoechst 33342 and fluorescent photomicro-
graphs of the blue, red, and green channels were taken. Hoechst stain (blue) shows nuclei. CMVp-GFP-HAP1-A7–598 was exclu-
sively cytoplasmic in all cells tested, where it assembled into strongly fluorescent STLBs. CMVp-DSRed2-TBP was exclusively 
nuclear with heterogenous subnuclear distributions when expressed alone. The negative controls, CMVp-DSRed2-PTIP, 
MED15, and U2AF65 (encoding nuclear proteins unrelated to TBP, see text), were also localized entirely to the nucleus when 
expressed alone. (B) co-expression of HAP1 with TBP, PTIP, MED15, or U2AF65. Co-expression of CMVp-GFP-HAP1 and 
CMVp-DSRed2-TBP shows that all HAP1 remained cytoplasmic, where it assembled into STLBs; however, TBP localization was 
altered. Thus, whereas much of the TBP still localized to the nucleus, a portion was sequestered into GFP-HAP1-STLBs. White 
arrows designate representative examples of extranuclear TBP in STLBs. As negative controls, DSRed2-PTIP, MED15, and 
U2AF65 were not detected in GFPHAP1-STLBs.BMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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our two-hybrid screens isolated a nearly full-length clone
of HAP1-A from the oligo(dT)-primed library and a
shorter clone from the random-primed library that
extended five amino acids past the HAP1 common region
into HAP1-B sequences. The nearly full-length HAP1-A
clone, when fused to the DSRed2 fluorescent protein,
formed strong STLBs and sequestered a fraction of co-
expressed TBP protein in all mammalian cell types tested
(Fig. 6). Interestingly, the short clone of HAP1-B (amino
acids 155–582, including only five HAP1-B-specific
amino acids) also assembled into STLBs and sequestered
TBP protein (Fig. 7A). In combination with previous stud-
ies [36,48], these results suggest that the HAP1-A-specific
C-terminal domain is not necessary for STLB assembly,
but rather, the HAP1-B-specific C-terminus antagonizes
STLB formation (see Discussion).
Although our two-component two-hybrid tests showed
that the TBP polyQ region was not required for the TBP-
HAP1 interaction (Fig. 2), the interaction of HAP1 with
other polyQ proteins has been shown to be influenced by
the length of polyQ repeats outside of their HAP1-binding
domains [6,12,27,49]. The length of the polyQ region in
vertebrate TBP proteins has been shown to be highly vari-
able both between and within species [50-52]; polyQ
expansion beyond 36 residues in human TBP causes
SCA17 [6]. Therefore, we wished to test whether, in the
context of a mammalian cell, we could detect quantitative
differences in the amount of TBP that assembled into
STLBs by altering the length of the polyQ repeat. Mutant
versions of mouse TBP expression vectors were con-
structed that either replaced the normal 13-residue polyQ
region with two glycines (TBP-∆Q) or expanded the
region nearly four-fold to contain 50 consecutive Q resi-
dues (TBP-Q50). When expressed alone, all three versions
of full-length TBP (wild-type, ∆Q, and Q50) were exclu-
sively nuclear (Figs 6A, 7B). When co-expressed with
HAP1, all three full-length TBP proteins showed partial
sequestration into cytoplasmic STLBs (Figs 6B, 7B).
To quantify the proportion of TBP proteins assembling
into STLBs, we co-transfected cells with GFP-HAP and
either DSRed2-TBP-FL, DSRed2-TBP-∆Q, or DSRed2-TBP-
Q50 and measured nuclear and extra-nuclear TBP fluores-
cence (Fig. 8). Results showed that, whereas both wild
type TBP and TBP-Q50 distributed similarly between the
nucleus and cytoplasm, TBP-∆Q exhibited significantly
less association with cytoplasmic STLBs.
Discussion
HAP1 is a predominantly cytoplasmic protein that has
been implicated in contributing to various processes
[42,53]. Since HAP1 has little similarity with other known
proteins [33], much of what is known about its function
has been discovered through identification of those pro-
teins that interact with HAP1. Specific protein interaction
sites on HAP1 have been mapped as follows (mouse
HAP1-B amino acid numbering): amino acids 277–369
(HAP1277–369) binds with Htt; full-length HAP1-A binds
to AR; HAP277–444  binds with dynactin P150Glued;
HAP1245–371 binds with hepatocyte growth factor-regu-
lated tyrosine kinase substrate protein; HAP11–312 binds
with interRho-GEF Kalirin-7; HAP1219–519 binds to GABAA
receptor; HAP1272–598  binds to IP31 receptor; and
HAP1247–446  binds to NeuroD (ND) [27,33,42,53-57].
Here we show that a clone encoding amino acids 155–
582 of HAP1 bound to the TBPCORE domain in yeast two-
hybrid screens (Fig. 2). We also show that TBP co-immu-
noprecipitated with HAP1 in transient cotransfection
assays (Fig. 3). Further, two regions within HAP1 were
shown to independently interact with TBP-C. Specifically,
the domains of HAP that interacted with TBP are found
between amino acids 157–261 and between amino acids
473–582 (Figs. 4 and 5).
We are aware of only one study that has shown a role of
HAP1 in transcriptional regulation. In that study, HAP1,
in conjunction with Htt, was shown to function as a scaf-
fold protein that mediates the interaction of ND with
mixed-lineage kinase 2 in the cytoplasm, resulting in
phosphorylation of ND and its subsequent translocation
to the nucleus [57]. No evidence exists for cytoplasmic
regulation of TBP activity, so we feel that it is unlikely that
the TBP-HAP1 interaction might similarly regulate gene
expression in HAP1-expressing cells. Rather, as detailed
below, we favor a model based on the 'HAP1 protection
hypothesis' [25], wherein HAP1 may help protect neuro-
nal cells from TBP-mediated cytotoxicity.
Including this report, HAP1 has now been shown to bind
specifically to three proteins associated with polyQ-
dependent neuropathologies: Htt, AR, and TBP
[4,5,27,53]. In all cases, recognition and binding of these
proteins by HAP1 is dependent on unique sequences out-
side of their polyQ regions [4,27]. In other words, HAP1
does not recognize an expanded polyQ repeat per se, but
rather, recognizes unique aspects of at least three specific
proteins that have a propensity for causing polyQ-
dependent neuropathology. Neruopathologies caused by
Htt, AR, and TBP are associated with nuclear accumula-
tion of protein aggregates, which are thought to induce
cytopathic effects resulting in apoptotic neuron loss
[1,3,20,53,58]. HAP1 is not associated with Htt aggregates
in HD brains and HD neuropathology is not associated
with brain regions having high HAP1 expression
[5,28,34]. Thus, although Htt is expressed in many
regions of the brain [59], regions that overlap with HAP1
expression are not vulnerable to neuropathology, leading
to formulation of the 'HAP1 protection hypothesis' [25].
Similarly, although both bulbar and forebrain neuronsBMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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HAP1 and TBP-FL, -∆Q, or -Q50 co-localization assays in COS-7 and Neuro-2a cells Figure 7
HAP1 and TBP-FL, -∆Q, or -Q50 co-localization assays in COS-7 and Neuro-2a cells. (A) Top two rows show cells transfected 
with a single expression plasmid: CMVp-GFP-TBP-FL (at left) and CMVp-DSRed2-HAP1-B155–582 (at right). GFP-TBP was exclu-
sively nuclear and RFP-HAP1 assembled into cytoplasmic STLBs. Bottom two rows show co-transfected cells containing GFP-
TBP and RFP-HAP1. Upon co-expression with HAP1, a portion of GFP-TBP became localized to the cytoplasmic, RFP-HAP1-
STLBs. (B) Top two rows show cells transfected with a single expression plasmid: CMVp-DSRed2-TBP-∆Q (at left) and CMVp-
DSRed2-TBP-Q50 (at right). Both RFP-TBP-∆Q and RFP-TBP-Q50 proteins localized exclusively to the nucleus when expressed 
alone. Cells co-transfected with GFP-HAP1-A7–598 and either RFP-TBP-∆Q (middle two rows) or RFP-TBP-Q50 (bottom two 
rows) showed altered localization of TBP away from the nucleus. RFP-TBP-∆Q, which lacks the polyQ repeat, and RFP-TBP-
Q50, which contains an expanded polyQ repeat, each were partially localized in the GFP-HAP1-STLBs.BMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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express high levels of AR, polyQ-expanded AR aggregates
and neuropathology in SBMA patients are not observed in
the forebrain regions, which express high levels of HAP1
and exhibit STBs, but rather, are restricted to the HAP1/
STB-deficient bulbar regions [25,27]. Overexpression of
polyQ-expanded AR in HEp-2 cells induces apoptosis;
however, co-overexpression of HAP1 suppresses apopto-
sis and, instead, causes formation of STLBs containing
both proteins [27]. Thus, HAP1 binds to polyQ-expanded
AR though specific interactions with regions outside the
polyQ domain, it sequesters polyQ-expanded AR in
STLBs, and it protects cells from polyQ-expanded AR-
induced apoptosis [27], strongly supporting a protective
role for HAP1.
Although it is not clear whether HAP1 might also protect
neurons from TBP-mediated neuropathology, it is intrigu-
ing that, despite ubiquitous expression of TBP in all cells
of the body, most regions of the brain exhibiting high lev-
els of HAP1 and abundant STBs do not exhibit neuropa-
thology in SCA17 patients [4-6,20,23,29]. One exception
is in the striatum, which has both STBs [34] and SCA17-
associated neuropathology [20,23]. However, detailed
analyses show that, whereas HAP1/STBs are found in the
medium and large neurons of the striatum [34], SCA17 is
associated with loss of the small neurons [20,23].
In the current study, we show that HAP1 binds specifically
to the TBPCORE and that HAP1 can sequester a subset of
TBP into STLBs in co-transfected 293, COS-7, or Neuro-2a
cells. Unlike the case for HAP binding to AR (see above),
the HAP1-TBP interaction in yeast or mammalian cells
did not require expansion of the polyQ region of TBP
(Figs 2B, 4, 7, 8); however, removal of the polyQ region
reduced assembly of TBP into STLBS (Figs 7, 8). Since the
HAP1-binding domains of TBP, Htt, and AR are all dispa-
rate from the polyQ regions in each protein (see above), it
is interesting that HAP1 binding by all three proteins
should show polyQ-dependence. In transfected cells,
HAP1/STLBs did not clear TBP from the nucleus (Fig. 6, 7,
8). Instead, they appeared to sequester a subset of TBP,
while still allowing substantial TBP accumulation in the
nucleus. It remains unclear whether the TBP protein that
accumulated in the nucleus was equivalent to that seques-
tered in the STLBs (Figs 6, 7, 8). One possibility is that the
polyQ region of each protein can influence the likelihood
that that protein assumes a "state" that allows interaction
with HAP1. For example, in the case of TBP, the subset of
protein that is sequestered into HAP1 STLBs might be mis-
folded, defective in nuclear localization, abnormally asso-
ciated with other proteins, or otherwise defective, thus
making this protein accessible for HAP1 binding. Further
studies will be required to better understand the role of
the TBP polyQ region in in vivo HAP1 association.
Conclusion
HAP1 has previously been shown to interact specifically
and away from the polyQ repeat region with Htt and AR
proteins, the causative agents of HD and SBMA, respec-
tively [27,53]. In the current study, we isolated HAP1 as a
PolyQ dependence of relative nuclear and cytoplasmic TBP  protein levels Figure 8
PolyQ dependence of relative nuclear and cytoplasmic TBP 
protein levels. (A) representative fluorescent photomicro-
graphs used for quantitative analyses. Cells were transfected 
with CMVp-GFP-HAP1-A7–598 and either CMVp-DSRed2-
TBP-FL, CMVp-DSRed2-TBP-∆Q, or CMVp-DSRed2-TBP-
Q50, as indicated at left. White dotted line delineates nuclei 
in each frame. (B) nuclear-cytoplasmic TBP distributions. 
Bars show average plus one standard deviation. Aserisks, 
cytoplasmic levels of TBP-∆Q were significantly less than 
those of TBP-FL, P < 0.05. Cytoplasmic levels of TBP-FL and 
TBP-Q50 were not significantly different.BMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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TBPCORE-interacting protein from unbiased two-hybrid
screens. The interacting domains were mapped and the
interactions were confirmed in co-immunoprecipitation
assays. Sub-cellular co-localization studies indicated that
HAP1-induced STLBs could sequester a subset of overex-
pressed TBP, but not other overexpressed nuclear pro-
teins, away from the nucleus. Although the co-
localization was modeled in an overexpression system, we
suspect this may be a suitable model for a HAP1-TBP
interaction. Thus, in normal cells, all TBP goes to the
nucleus where it functions in transcription initiation and
a HAP1-TBP interaction would not occur. Only in the case
of a TBP expression anomaly would there be a possible
physiological situation in which a HAP1-TBP interaction
may be important to combat TBP-mediated cytotoxicity.
In our co-localization system, the anomaly is strong over-
expression of TBP in the transiently co-transfected cells; in
SCA17 patients, anomalous expansion of the TBP polyQ
repeat results in overaccumulation TBP, which assembles
into nuclear aggregates and results in apoptotic neuronal
loss [6]. Interestingly, neurons expressing HAP1 and pos-
sessing STBs appear to be refractory to nuclear aggregate
formation and SCA17 cytopathology (see above). Thus,
we posit that HAP1 plays a neuroprotective role in pre-
venting nuclear aggregate formation in the presence of
anomalous TBP accumulation.
Methods
Material availability
All renewable reagents generated for this study, including
all plasmids, expression vectors, yeast two-hybrid librar-
ies, and yeast strains, are available on request for unre-
stricted non-profit research use unless specifically
regulated by other parties.
Two-hybrid baits, libraries, transformations, and screens
TBP baits were generated by polymerase chain reaction
(PCR) from a plasmid containing the predominant
mouse (Mus musculus) somatic TBP cDNA [52,60]. Full-
length TBP (TBP-FL) was amplified by PCR using TBP-N-
start-Sal I primer and TBP-C-end primer; the TBP N termi-
nus clone (TBP-N), which encoded amino acids 1–136,
was amplified using TBP-N-start-Sal I primer and TBP-N-
end primer; the TBPCORE clone (TBP-C), which encoded
amino acids 134–316, was amplified using TBP-C-start
primer and TBP-C-end primer (Table 1). TBP-FL and TBP-
N were cut with Sal I and Not I and inserted into the pDB-
Leu bait vector (Gibco BRL ProQuest Two-Hybrid Sys-
tem). TBP-C was digested with Nco  I and Not  I and
inserted into pDBLeu. TBP-∆Q was constructed using
primers TBP-N-start-Sal I and TBP-∆Q and inserted into a
plasmid containing the TBP-N. The TBP-∆Q N region was
then sub-cloned into TBP-FL. The resulting clone inserts a
Gly-Gly linker in place of the polyQ repeat region (amino
acids 55–70 of the mouse TBP-FL protein). TBP-∆Q was
digested with Sal I and Not I and was inserted into pDB-
Leu. Truncated TBPCORE  clones were constructed as
described [61] and were inserted between Sal I and Not I
in the pDBLeu plasmid.
Oligo(dT)-primed cDNA prey libraries were constructed
and inserted into the pPC86 vector (Gibco BRL ProQuest)
as follows. Total RNA was extracted and CsCl-purified
[22] from embryonic day 10.5 (E10.5) wild-type C57Bl/6J
whole pregnant uteri or placentas. In each case, either
whole pregnant uteri or placentas were obtained from
four pregnant dams to generate a pool of RNA. Poly(A+)
mRNA from these samples was purified using Oligo(dT)25
Dynabeads (Dynal Biotech ASA) following the manufac-
turer's protocols. Oligo(dT)-primed libraries were con-
structed from ~3 µg of poly(A+) RNA; cDNA inserts for
each library had an average size of >1 kb (Fig. 1B). The
whole pregnant uteri and placental libraries contained
~2.1 × 106 and ~2.5 × 106 independent recombinants,
respectively; each with ~95% bearing inserts (Fig. 1B). To
access more 5' regions of prey cDNAs, a random hexamer-
primed library was also constructed using 3 µg each of
whole pregnant uteri and placental poly(A+) RNA. Con-
struction of random-primed cDNAs was performed using
a standard oligo(dT)-primed cDNA synthesis kit (Strata-
gene), with the following adaptations. First, instead of an
oligo(dT) primer, random hexamer oligonucleotides were
used to prime the first-strand cDNA. Second, a linker con-
taining a 5' Eco RI overhang and a blunt 3' end was con-
structed by annealing the 5' and 3' linker oligos (Table 1)
and ligating this to the blunt-ended double-strand cDNA
product. Both the 5' and 3' ends of the cDNA had Eco RI
overhangs (Table 1), which allowed direct insertion of the
library product into an Eco RI-digested vector. Two ver-
sions of the random-primed library were constructed and
subsequently pooled. The first consisted of non-amplified
cDNA that was inserted into the Eco RI site of pPC86. This
library contained ~6 × 105 primary transformants with
~60% bearing inserts. The second library was constructed
from random-primed cDNA that had been amplified by
PCR using primers that annealed to the linker sequences
located at the 5' and 3' ends of the final cDNA library
product. PCR-amplified cDNA was digested with Not  I
and inserted into the Not I site of pPC86. This library con-
tained ~1.8 × 106 independent recombinants with ~90%
bearing inserts. After pooling, the combined library con-
sisted of ~2.4 × 106 cDNA clones and had an average insert
size of ~1.0 kb with ~90% bearing inserts (Fig. 1B).
All interactions were tested in Saccharomyces cerevisiae
strain MaV203 (Gibco BRL), which contained the HIS3,
URA3, and LacZ reporters, each under the control of a dif-
ferent promoter. For library transformations, a culture of
MaV203 that contained the TBP bait construct was grown
at 30°C for 48 hours in liquid synthetic completeBMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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medium (SC) lacking leucine (SC-L) (QBIOgene). This
culture was used to seed 300 ml of 2× yeast extract/pep-
tone/adenine/dextrose (YPAD) at 5 × 106 yeast/ml, which
was determined by counting on a hemacytometer. The
culture was grown at 30°C for ~5 hours to a density of 2
× 107 yeast/ml. Yeast were collected by centrifugation,
washed once with water and once with 100 mM LiAc, and
transformed with 14.4 ml 50% PEG (average m.w. 3350),
2.16 ml 1.0 M LiAc, 0.3 ml 10 mg/ml sheared denatured
salmon sperm DNA, and 120 µg of the cDNA library in
pPC86. Single- or two-component transformations of bait
and/or prey plasmids into yeast used a standard PEG/LiAc
protocol [62].
Two-hybrid screens were performed on SC medium lack-
ing leucine, tryptophan, histidine, and uracil (SC-L-W-H-
U). Both two-hybrid screens used TBP-FL as bait to screen
either a combination of 50% whole pregnant uteri and
50% placental (screen 1) or random-primed (screen 2)
cDNA prey libraries. Primary transformants were trans-
ferred onto a new SC-L-W-H-U plate and clones that grew
well on these plates were transferred to either a SC-L-W-H
+ 80 mM 3-AT plate or were grown on SC-L-W and tested
for LacZ expression following the X-Gal Assay protocol
detailed in the ProQuest Two-Hybrid system manual
(Gibco BRL cat. series 10835). Prey plasmids from clones
that grew under all selection conditions and scored posi-
tive for LacZ expression (turned blue) were isolated from
yeast by glass bead lysis [63]. Recovered plasmids were
transformed into bacteria, clones were selected, and
inserts were sequenced to determine the cDNA identity.
Isolated prey plasmids were re-transformed into MaV203
with the bait or with the empty pDBLeu plasmid (auto-
activation test) and grown on SC-L-W-H + 75 mM 3-AT,
and SC-L-W-H-U plates to verify the interaction.
To identify the domain of TBP that interacted with HAP1,
TBP bait constructs in combination with the empty
pPC86 prey plasmid (auto-activation test) or with either
the HAP1 random-primed or the HAP1 oligo(dT)-primed
clone were co-transformed into MaV203 and plated onto
SC-L-W. Individual colonies that grew on SC-L-W plates
(containing both the bait and prey plasmid) were sus-
pended in water and streaked onto SC-L-W, SC-L-W-H +
75 mM 3-AT, and SC-L-W-H-U plates to verify the interac-
tion.
Interaction domain mapping
For generating a HAP1 deletion mutant series, a random-
primed yeast two hybrid prey plasmid isolated as a TBP
interactor, encoding amino acids 155–582 of the mouse
HAP1-B cDNA, was used as the template for PCR amplifi-
cation. PCR primer sets for amplification of each trun-
cated clone are indicated in Table 1. PCR products were
Table 1: Oligonucleotide sequences
name sequence1
GFP-N-start 5'-tatgcggccgcgtcgaccatggtgagcaagggcgaggagct-3'
GFP-C-end 5'-tatgcggccgcagtcgacttgtacagctcgtccatgcc-3'
HAP1-157-forward 5'-tatgtcgacagaacgggacctgaacacagc-3'
HAP1-238-forward 5'-tatgtcgacacagagggatcaagaccagca-3'
HAP1-300-forward 5'-tatgtcgacgatgctcattctggaatgtgtg-3'
HAP1-380-forward 5'-tatgtcgacctcctacatgcaggattatggg-3'
HAP1-473-forward 5'-tatgtcgacagatctcaagccacctgaagat-3'
HAP1-261-reverse 5'-tatgcggccgctgtctcagccttagggtgt-3'
HAP1-306-reverse 5'-tatgcggccgcacacattccagaatgagcatc-3'
HAP1-386-reverse 5'-tatgcggccgcccataatcctgcatgtaggag-3'
HAP1-478-reverse 5'-tatgcggccgctcttcaggtggcttgagatctt-3'
HAP1-582-reverse 5'-tatgcggccgcgttggggagtcttttgggacca-3'
TBP-N-start-Sal I5 ' - a t c gtcgactatggaccagaacaacagccttcca-3'
TBP-N-start-Bgl II 5'-tatagatctatggaccagaacaacagccttc-3'
TBP-N-end 5'-atagcggccgcttaagagctctcagaagctggtgtggca-3'
TBP-C-start 5'-tatggatccaccatggaccagagctctggaattgtaccgcagcttca-3'
TBP-C-end 5'-gctagcggccgcccaagtagcagcacagagc-3'
TBP-Q50 5'-
atactgcagttgctactgcctgttgctgctgttgctgctgctgttgctgttgctgctgttgctgttgctgctgttgttgctgctgctgttgctgctgctgctgttgttgctgctgttgctgctg
ttgctgctgctgttgttgctgctgctgttgctgttgctgctgctgtctttgttgctcttccaaaatagagagact-3'
TBP-∆Q5 ' - a t g c a ctgcagtcgcgacagctccgccctcttccaaaatagagagact-3'
U2AF-N-start 5'-tatgtcgaccatgtcggacttcgacgagttcgag-3'
U2AF-C-end 5'-tatgcggccgccggtggtaagaatcagggtca-3'
linker (top strand) 5'-aattcgcggccgcgtcgac-3'
linker (bottom strand) 5'-phos-gtcgacgcggccgcg-3'
1Endogenous protein-coding sequences are in bold and engineered restriction sites are in italics.BMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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digested with Sal I and Not I and were inserted into the
pPC86 prey vector.
Three plasmid clones of each truncated HAP1 construct
were isolated and separately co-transformed into yeast
with pDBLeu-mTBP-N, pDBLeu-mTBP-C, or empty pDB-
Leu bait plasmid. Yeast were plated onto SC-L-W agar
plates and grown at 30°C. Resultant colonies were sus-
pended in water and streaked onto SC-L-W, SC-L-W-H +
75 mM 3AT, and SC-L-W-H-U to test each protein interac-
tion pair.
TBP-∆Q and truncated TBP-C clones were co-transformed
into yeast with pPC86-mHAP1-A7-598 or the empty pPC86
prey plasmid. Yeast were plated onto SC-L-W agar plates
and grown at 30°C. Two resultant colonies for each yeast
co-transfection were suspended in water and streaked
onto SC-L-W, SC-L-W-H + 75 mM 3AT, and SC-L-W-H-U
to test each protein interaction pair.
Co-immunoprecipitation assays
A HAP1 cDNA encoding amino acids 155–582 of the
mouse HAP1-B protein was inserted into the Eco RI site of
pCMV-MYC (BD Biosciences). The TBP-FL cDNA was
inserted between the Sal I and Not I sites in both pCMV-
HA (BD Biosciences) and pFLAG-CMV-2SN, which is a
modified version of pFLAG-CMV-2 (Sigma). pFLAG-
CMV-2SN contained a modified polylinker, and was con-
structed by inserting a linker oligonucleotide containing
internal Sal I and Not I sites and a 5' Hind III and 3' Bam
HI into Hind III/Bam HI-digested pFLAG-CMV-2. A green
fluorescent protein- (GFP-) tagged TBP construct, pFLAG-
CMV-GFP-TBP-FL, was constructed by PCR amplification
of EGFP with primers GFP-N-start and GFP-C-end (Table
1). PCR-amplified EGFP was digested with Sal  I and
inserted into the Sal I site upstream of TBP-FL in pFLAG-
CMV-2SN.
Line 293 cells were transfected and lysates were prepared
as described previously [61]. Lysates were pre-adsorbed
with 10 µl of non-specific rabbit polyclonal antibody and
20 µl of Protein G plus Protein A agarose (Calbiochem)
for 2 hours, rotating at 4°C, after which the agarose was
pelleted and 0.5 ml of supernatant was transferred to a
new tube containing 12.5 µl of either anti-TBP NC rabbit
polyclonal antibody [61] or a non-specific control anti-
body and rotated at 4°C for 16 hours, followed by one
hour with 30 µl of Protein G plus/Protein A agarose
added. Beads were washed once with lysis buffer, four
times with wash buffer (50 mM Tris-HCl, pH 7.4, 300 mM
NaCl, 2% TX-100, 10% glycerol, and 1 mM PMSF), and a
final time with wash buffer that contained 100 mM NaCl.
Proteins bound to agarose beads were released by boiling
for 5 minutes in 1× SDS-PAGE sample buffer, separated
by polyacrylamide gel electrophoresis, and analyzed by
Western blotting with the antibodies indicated in figure
legends.
COS-7 cells at 40–50% confluence on 10 cm dishes were
transfected and lysates were prepared as described previ-
ously [61], with the following modifications. Cells were
lysed in 750 µl of lysis buffer (50 mM Tris, pH 7.4, 150
mM NaCl, 1% TX-100, 0.1% SDS, 0.5% deoxycholic acid,
10% glycerol, 1 mM EDTA, 1 mM PMSF, 5 µg/ml leupep-
tin-pepstatinaprotinin, and 0.1 mM Na3V04). After lysis,
cells were brought to a final volume of 1.5 ml with 150
mM NaCl wash buffer (50 mM Tris, pH 7.4, 150 mM
NaCl, 1% TX-100, 10% glycerol, 1 mM EDTA, 1 mM
PMSF, 0.5 µg/ml leupeptin-pepstatin-aprotinin, and 0.1
mM Na3V04). Lysates were pre-adsorbed with 2 µg of non-
specific mouse monoclonal antibody and 20 µl of Protein
G plus Protein A agarose (Calbiochem) for 2 hours, rotat-
ing at 4°C, after which the agarose was pelleted and 1.4
ml of supernatant was transferred to a new tube contain-
ing 5 µg of either anti-FLAG M2 monoclonal antibody
(Sigma) or a non-specific control antibody and rotated at
4°C for 16 hours, followed by one hour with 40 µl of Pro-
tein G plus/Protein A agarose added. Beads were washed
once with 150 mM NaCl wash buffer, three times with
300 mM NaCl wash buffer (50 mM Tris-HCl, pH 7.4, 300
mM NaCl, 2% TX-100, 10% glycerol, 0.5 µg/ml leupeptin-
pepstatin-aprotinin, and 1 mM PMSF), and a final time
with 150 mM NaCl wash buffer. Proteins bound to agar-
ose beads were released by boiling for 5 minutes in 1×
SDSPAGE sample buffer, separated by polyacrylamide gel
electrophoresis, and analyzed by Western blotting with
the antibodies indicated in the figure legend.
In vivo co-localization assays
For co-localization assays, a full-length cDNA of mouse
TBP was PCR-amplified with TBPN-start-Bgl II and TBP-C-
end primers (Table 1), and inserted between the Bgl II and
Kpn I sites in the pDsRed2-C1 plasmid (BD Biosciences).
TBP-∆Q was inserted between the Sal I and Not I sites in
pDsRed2-C1SN, which is a modified version of pDsRed2-
C1. pDsRed2-C1SN was constructed by inserting a linker
oligonucleotide containing internal Sal I and Not I sites
and 5'Eco RI and 3' Bam HI overhangs into Eco RI/Bam HI-
digested pDsRed2-C1. TBP-Q50  was constructed using
primers TBP-N-start-Sal I and TBP-Q50 and inserted into a
plasmid containing the TBP-N-terminus. The TBP-N-ter-
minal clone containing a polyQ-repeat region expanded
from 13- to 50-Q residues was then sub-cloned into TBP-
FL, which was inserted into pDsRed2-C1SN for use in co-
localization assays.
As controls, three additional cDNAs were inserted into
pDSRed2-Cl (MED15) or pDSRed2-C1SN  (PTIP and
U2AF65). Clones were as follows: amino-acids 429–1056
of the nuclear protein PTIP [45]; the full-length mouseBMC Molecular Biology 2007, 8:76 http://www.biomedcentral.com/1471-2199/8/76
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MED15 open reading frame (ATCC, catalog no.
10699004; NCBI accession number BC054779); and full-
length mouse U2AF65  (NCBI accession number
BC106134) [46,47], which was isolated by RT-PCR and
subsequent PCR amplification of mouse C57Bl/6J cDNA
with primers U2AF-N-start and U2AF-C-end (Table 1).
A GFP-tagged HAP1 protein was constructed by PCR
amplification of EGFP with primers GFP-N-start and GFP-
C-end (Table 1). The EGFP PCR product was digested with
Sal I and inserted into the Sal I site upstream of HAP1-A7–
598 in the pCMV-MYC plasmid. This resultant construct
was termed pCMV-MYC-GFP-HAP1-A7–598. A red fluores-
cent protein- (RFP-) tagged HAP1 protein was also con-
structed by insertion of HAP1-B155–582 into the Sal I site in
pDSRed2-C1.
Cell transfection conditions for 293, COS-7, and Neuro-
2a cells were similar to those performed for co-immuno-
precipitation assays except that 0.5 µg of each plasmid was
used for each transfection. In single plasmid transfections,
total DNA was brought to 1 µg with pBluescript II KS+
plasmid (Stratagene). Forty-eight hours after transfection,
cells were stained with Hoechst 33342 (Sigma) at 1.0 µg/
ml in PBS for 15 min, rinsed once, given fresh complete
medium, and photographed on a Nikon Eclipse TE300
inverted fluorescent microscope.
Quantitation of relative nuclear and extranuclear TBP
COS-7 cells were transfected as above with the fluorescent
fusion proteins indicated in figure legend. Forty-eight
hours after transfection, cells were stained with Hoechst
and digital fluorescent photomicrographs of cells express-
ing both HAP1 and TBP were taken (ten or more co-
expressing cells per experimental condition were chosen
arbitrarily). Hoechst and GFP-HAP1 fluorescence were
used to delineate nuclear and cytoplasmic regions, as indi-
cated by white dotted lines in Fig 8A. Because adherent
cells have little cytoplasm over- or under-lying the
nucleus, most cells gave clear spatial separation of GFP-
HAP1 STLB fluorescence and nuclear Hoechst fluores-
cence; however, a few cells did have evidence of STLBs
over- or under-lying the nucleus, and these were excluded
from the analysis.
Digital photomicrographs of individual cells were used to
estimate relative nuclear and extranuclear TBP levels.
Total area, nuclear area, and extranuclear area were ana-
lyzed using the "Image Histogram" tool for the red
(DSRed2-TBP expression) channel within Photoshop 7.0
(Adobe). The pixel-count per intensity level curve was
integrated to provide a quantitative estimate of the total
amount of red fluorescence in each compartment.
Because this integration takes into account the fluores-
cence intensity in each pixel, it converts the two-dimen-
sional fluorescent photomicrograph into a quantitative
representation of all fluorescence in the three-dimen-
sional space within each cellular region, and thus provides
an estimate of relative fluorescent protein concentrations.
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